Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IM flumazenil for coma after unintentional benzodiazepine overdose
ISRCTN14373275Phase 3Recruiting
- Sponsor
- University of Edinburgh
- Start
- Jan 2025
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of flumazenil in benzodiazepine overdose (12 arms), sponsored by University of Edinburgh. Primary endpoints: Tonic-clonic seizure within 1 hour and RASS in -2 to 0 range at 15 minutes. Started Jan 2025; status: recruiting.
02
Drugs
flumazenil
03
Conditions
benzodiazepine overdose
Beyond the preview
Go deeper on ISRCTN14373275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14373275.